Switch, Inc., a trailblazer in exascale data center ecosystems and cutting-edge telecommunications solutions, has proudly announced a groundbreaking funding round that raised an impressive $4.25 billion. This monumental investment underscores the growing demand for advanced data center designs and robust technological infrastructures as the world increasingly transitions into a data-driven paradigm. Founder and CEO Rob Roy, a visionary in the industry, has been instrumental in this journey, having developed over 700 issued and pending patent claims that have solidified Switch’s reputation for innovation. The newly acquired funds will be strategically allocated to further enhance their industry-leading edge data center designs, catalyze the expansion of their global footprint, and spearhead research and development initiatives aimed at next-generation technology innovations. This funding will not only fuel the growth of Switch, Inc. but also enable the company to remain at the forefront of advancements in data solutions that meet the escalating demands of businesses and consumers alike. With this financial backing, Switch aims to revolutionize the future of data management, increase operational efficiency, and drive sustainability initiatives within the technology sector. As Switch continues to break new ground, it is poised to redefine the landscape of data centers and telecommunications, ensuring that organizations worldwide benefit from unparalleled performance and reliability in their digital infrastructures.
Switch Secures $4.25 Billion in Funding for Future Technology Innovation
Get the full Switch company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Capital B
Capital B is a nonprofit local/national news organization for Black audiences. Cofounded by veteran news leaders Lauren Williams and Akoto Ofori-Atta, Capital B deliver quality, trustworthy, original reporting to Black people across the country.
$17.8M Unknown
today
Prisma Labs, Inc.
Prisma Labs is a mobile technology company specialising in deep learning-related products. Our goal is to move forward mobile photography and video creation to the next level using neural networks, deep learning and computer vision technics. We aim to create new ways for people to express their emotions through the camera.
$100.0K Unknown
today
Atro
Atro is a venture-backed cybersecurity platform for SMBs, MSPs, and insurance providers that makes protecting sensitive data an entirely stress-free experience. Built by a team of world-class experts who understand the struggles of starting small, Atro is dedicated to solving cyber disparities with solutions that are accessible to every business owner. Want to see Atro in action? Watch our product demos here: https://www.youtube.com/@Atro-Cybersecurity/playlists
$100.0K Unknown
today
3D Bio-Tissues ltd - powered by BSF plc
3D Bio-tissues (3DBT) is a biotechnology company redefining the efficiency of cell-based therapies and cellular agriculture. We specialize in the development of macromolecular crowders—simple, powerful media additives designed to mimic the natural physiological environment, accelerating growth and significantly reducing operational costs. At the core of our innovation is a commitment to making complex biology scalable. By optimizing the way cells interact with their environment, we help our partners move from lab-scale success to industrial-scale reality. Our Core Solutions: CityMix™ | Transforming Cultivated Meat: The biggest barrier to cultivated meat is the cost of media. CityMix™ is a patented macromolecular crowder that reduces the requirement for expensive growth factors and supplements. It enables higher yields and faster production times, making sustainable, slaughter-free meat commercially viable. CytoBoost™ | Powering Biopharmaceutical Science: Precision matters in bioprocessing. CytoBoost™ enhances the performance of cell lines used in drug discovery and therapeutic production. It stabilizes proteins and improves cellular productivity without complex media reformulations. CytoBoost™ REVIVE | The Post-Thaw Cell Enabler: Cryopreservation is a critical stressor for cells. CytoBoost™ REVIVE is specifically formulated to act as a post-thaw enabler, minimizing the "lag phase" and maximizing cell viability and recovery. It ensures that your research or production starts with the strongest biological foundation possible. Why 3DBT? We don’t just provide additives; we provide the tools for the next generation of life sciences. Whether you are aiming to lower the price of a cultivated steak or increase the yield of a life-saving biologic, our macromolecular crowding technology is the "plug-and-play" solution your bioprocess needs.
$100.0K Unknown
today
Idelic
Idelic’s Safety Suite is a modern Driver Safety Management System for fleets. Centralize your driver data, detect hidden risk earlier, and empower your team to coach drivers before preventable accidents happen—all in one platform.
$20.0M Series b
today